Bank of America
DYN icon

Bank of America’s Dyne Therapeutics DYN Stock Holding History

Bank of America’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.2M Buy
1,443,313
+560,391
+63% +$9.66M ﹤0.01% 2167
2025
Q4 		$17.3M Buy
882,922
+121,810
+16% +$2.31M ﹤0.01% 2423
2025
Q3 		$9.63M Buy
761,112
+247,311
+48% +$2.82M ﹤0.01% 3343
2025
Q2 		$4.89M Buy
513,801
+243,825
+90% +$2.68M ﹤0.01% 3921
2025
Q1 		$2.82M Buy
269,976
+147,335
+120% +$2.11M ﹤0.01% 4365
2024
Q4 		$2.89M Sell
122,641
-169,071
-58% -$5M ﹤0.01% 4118
2024
Q3 		$10.5M Buy
291,712
+114,938
+65% +$4.57M ﹤0.01% 3029
2024
Q2 		$6.24M Buy
176,774
+24,142
+16% +$702K ﹤0.01% 3417
2024
Q1 		$4.33M Buy
152,632
+111,850
+274% +$2.53M ﹤0.01% 3746
2023
Q4 		$542K Sell
40,782
-52,979
-57% -$518K ﹤0.01% 5431
2023
Q3 		$840K Buy
93,761
+2,029
+2% +$21.9K ﹤0.01% 4947
2023
Q2 		$1.03M Buy
91,732
+19,761
+27% +$233K ﹤0.01% 4756
2023
Q1 		$829K Buy
71,971
+36,205
+101% +$470K ﹤0.01% 5025
2022
Q4 		$415K Sell
35,766
-15,053
-30% -$174K ﹤0.01% 5511
2022
Q3 		$645K Buy
50,819
+22,510
+80% +$258K ﹤0.01% 5210
2022
Q2 		$195K Sell
28,309
-4,463
-14% -$30.7K ﹤0.01% 6115
2022
Q1 		$316K Sell
32,772
-31,247
-49% -$266K ﹤0.01% 6149
2021
Q4 		$762K Buy
64,019
+50,716
+381% +$713K ﹤0.01% 5518
2021
Q3 		$216K Sell
13,303
-335
-2% -$5.94K ﹤0.01% 6254
2021
Q2 		$287K Buy
13,638
+433
+3% +$8.14K ﹤0.01% 5832
2021
Q1 		$205K Buy
13,205
+566
+4% +$11K ﹤0.01% 6021
2020
Q4 		$265K Buy
+12,639
New +$250K ﹤0.01% 5415

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Bank of America's DYN Position: Q1 2026 in Review

Bank of America increased its Dyne Therapeutics (DYN) stake by 63% in Q1 2026, buying an estimated $9.66M and bringing the position to 1,443,313 shares worth $26.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2167.

Bank of America first reported a position in DYN in Q4 2020 and has held it in 22 quarters since. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Bank of America held 1,443,313 shares of Dyne Therapeutics worth $26.2M as of Q1 2026.
  • Bank of America bought 560,391 Dyne Therapeutics shares in Q1 2026, an estimated $9.66M.
  • Dyne Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2167 holding.
  • Bank of America first reported a position in Dyne Therapeutics in Q4 2020 and has held it in 22 quarters since.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.